Concepedia

Rajesh Devraj

RD

29

Publications

2.5K

Citations

22

H-Index

1991

Active since

Affiliations

Pfizer (United States)(Current)

Duquesne University

Eli Lilly (United States)

Experimental Station

Purdue University West Lafayette

Rajesh Devraj is an author at Pfizer (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1991–2021

29

Publications

29

Physiochemical drug properties associated with in vivo toxicological outcomes

Jason D. Hughes, Julian Blagg, David A. Price et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 945 citations

, , +5

Chemical Library Purification Strategies Based on Principles of Complementary Molecular Reactivity and Molecular Recognition

Daniel L. Flynn, J. Z. CRICH, Rajesh Devraj et al. · Journal of the American Chemical Society · 1997 · 211 citations

Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate

Robert Hughes, Todd Bosanac, Xianrong Mao et al. · Cell Reports · 2021 · 175 citations · Full text

Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy

Todd Bosanac, Robert Hughes, Thomas M. Engber et al. · Brain · 2021 · 144 citations · Full text

cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons

Yo Sasaki, Thomas M. Engber, Robert Hughes et al. · Experimental Neurology · 2020 · 116 citations · Full text

, , +10

Rows per page

1–5 of 29